Dementia CURE? UK charity ‘welcomes’ stem cell treatment research – Express.co.uk
Express.co.uk |
Dementia CURE? UK charity ‘welcomes’ stem cell treatment research
Express.co.uk Its comments came after scientists revealed stem cells were needed to replace neurones that have been lost in dementia patients. The cells – which can be moulded by scientists to become any type of cell in the body – also help to revitalise stressed … |
|
Dstl details synthetic biology armour progress
IHS Jane’s 360 The UK’s Defence and Science Technology Laboratory (Dstl) synthetic biology (SynthBio) armour programme is at Technology Readiness Level 3, with samples currently able to undergo hardness testing, Dstl representatives have told Jane’s . They also … |
|
Long-lasting blood vessel repair in animals via stem cells
Science Daily Stem cell researchers at Emory University School of Medicine have made an advance toward having a long-lasting “repair caulk” for blood vessels. The research could form the basis of a treatment for peripheral artery disease, derived from a patient’s … |
|
Cutting-edge immunotherapy treatment approved for another deadly cancer
Kankakee Daily Journal The one-time infusion, known as CAR T-cell therapy, is made by Kite Pharma, which is based in Santa Monica, Calif., and recently was bought by Gilead Sciences for $11.9 billion. Kite announced Wednesday the treatment’s brand name will be Yescarta and … |
Newshawk Time |
Global Cancer Immunotherapy Market Report 2017-2022
PR Newswire (press release) reveals that the cancer immunotherapy space will be a significant revenue generator (excess of $80 billion) for the biopharmaceutical industry by 2020. The market has been supported by the approval of Bristol-Myers’ Yervoy drug for melanoma, BMS’s … Global Cancer Immunotherapy Market Analysis & Forecast to 2022 – Research and MarketsBusiness Wire (press release) Cancer Immunotherapy Market Analysis, Industry Chain Related Technical Experts Analysis and Forecasts Till 2021Digital Journal Immunotherapy Drugs Market : Size, Share, Analysis and Forecast 2025Medgadget (blog) |